Bed nucleus of the stria terminalis α1- and α2-adrenoceptors differentially modulate the cardiovascular responses to exercise in rats  by Alves, F.H.F. et al.
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Abstract—Dynamic exercise evokes sustained blood pres-
sure and heart rate (HR) increases. Although it is well ac-
cepted that there is a CNS mediation of cardiovascular ad-
justments during dynamic exercise, information on the role
of specific CNS structures is still limited. The bed nucleus of
the stria terminalis (BST) is involved in exercise-evoked cardio-
vascular responses in rats. However, the specific neurotrans-
mitter involved in BST-related modulation of cardiovascular
responses to dynamic exercise is still unclear. In the present
study, we investigated the role of local BST adrenoceptors in
the cardiovascular responses evoked when rats are submitted
to an acute bout of exercise on a rodent treadmill. We observed
that bilateral microinjection of the selective 1-adrenoceptor
ntagonist WB4101 into the BST enhanced the HR increase
voked by dynamic exercise without affecting the mean arterial
ressure (MAP) increase. Bilateral microinjection of the selec-
ive 2-adrenoceptor antagonist RX821002 reduced exercise-
evoked pressor response without changing the tachycardiac
response. BST pretreatment with the nonselective -adreno-
ceptor antagonist propranolol did not affect exercise-related
cardiovascular responses. BST treatment with either WB4101
or RX821002 did not affect motor performance in the open-field
test, which indicates that effects of BST adrenoceptor antago-
nism in exercise-evoked cardiovascular responses were not
due to changes in motor activity. The present findings are the
first evidence showing the involvement of CNS adrenoceptors
in cardiovascular responses during dynamic exercise. Our re-
sults indicate an inhibitory influence of BST 1-adrenoceptor
on the exercise-evoked HR response. Data also point to a facili-
tatory role played by the activation of BST 2-adrenoceptor on
the pressor response to dynamic exercise. © 2011 IBRO. Pub-
lished by Elsevier Ltd.
Key words: central nervous system, noradrenergic neu-
rotransmission, adrenoceptors, dynamic exercise, treadmill,
open-field test.
Physical exercise requires a higher blood flow in working
muscles in order to match the increase in metabolic de-
mand (Waldrop et al., 1996; Rowell, 1997). Therefore,
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Open access under the Elsevier OA lheart rate (HR), cardiac output and arterial pressure in-
crease during exercise (Waldrop et al., 1996; Rowell,
1997). Moreover, sympathetic-mediated vasoconstriction
diverts blood away from the kidneys and splanchnic re-
gions, thus redistributing the blood flow to active muscles
(Amaral and Michelini, 1997; Rowell, 1997; Miki et al.,
2003). These cardiovascular adjustments are controlled by
the CNS through several neural mechanisms. The central
command is a feed-forward mechanism originating in tel-
encephalic regions that involves a parallel activation of
brain stem and spinal circuits responsible for the control of
locomotion as well as cardiovascular activity during exer-
cise (Raven et al., 2002; Williamson et al., 2006). Cardio-
vascular responses during exercise are also driven by
neural feedback from working muscles, which are stimu-
lated by mechanical changes or metabolic products origi-
nating in active muscles (Kaufman and Forster, 1996;
Fisher and White, 2004). Cardiovascular changes during
exercise are accompanied by a resetting of baroreflex
toward higher blood pressure values (Rowell and O’Leary,
1990; Raven et al., 2006). It has been proposed that the
increase in sympathetic nerve activity and arterial pressure
observed during exercise depends on an upward shift of
the operating point of the arterial baroreflex (Ludbrook and
Potocnik, 1986; DiCarlo and Bishop, 1992). Although the
neural mechanisms are well established, the specific nu-
clei and CNS neural pathways involved in cardiovascular
responses to exercise are still poorly understood.
The bed nucleus of the stria terminalis (BST) is localized
in the rostral prosencephalon, and is associated with auto-
nomic and neuroendocrine functions (Dunn, 1987; Gelsema
and Calaresu, 1987; Hatam and Nasimi, 2007; Alves et al.,
2009; Crestani et al., 2009b). Previous results from our lab-
oratory showed that bilateral microinjection of the unspecific
neurotransmitter blocker CoCl2 into the BST of rats reduced
both pressor and tachycardiac responses evoked by an
acute bout of exercise on a rodent treadmill (Crestani et al.,
2010b). These results indicated a role of the BST in cardio-
vascular adjustments during dynamic exercise in rats. How-
ever, due to the nonselective blockade of local neurotrans-
mission caused by CoCl2 (Kretz, 1984; Lomber, 1999), the
pecific neurotransmitter involved in the BST-related modu-
ation of cardiovascular responses to exercise is yet un-
nown.
Previous evidence has suggested an involvement of
he CNS noradrenergic pathway in adjustments observed
uring exercise (Lambert and Jonsdottir, 1998; Higa-Tani-
uchi et al., 2007). It has been reported that running on a
readmill markedly activates neurons in A1, A2 and A6
icense.
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F. H. F. Alves et al. / Neuroscience 177 (2011) 74–83 75noradrenergic neurons in the brain stem of rats (Timofeeva
et al., 2003; Ohiwa et al., 2006). Exercise on the treadmill
also enhances noradrenaline release and turnover rate in the
CNS (Pagliari and Peyrin, 1995; Kitaoka et al., 2010; Takatsu
et al., 2010). Moreover, administration of the selective 2-
adrenoceptor agonist clonidine attenuates increases in arte-
rial pressure and HR elicited during static muscle contraction
when injected either intracisternally, intrathecally, into the
cerebral aqueduct or microdialyzed into the L7 dorsal horn of
the spinal cord of anesthetized cats (Williams, 1985; Williams
et al., 1987; Hill and Kaufman, 1991; Ally et al., 1996). Al-
though the above results suggest involvement of the central
noradrenergic pathway in cardiovascular adjustments during
exercise, its role in cardiovascular responses to dynamic
exercise has never been investigated.
Among the numerous neural inputs to the BST, norad-
renergic synaptic terminals are prominent in the BST (Phe-
lix et al., 1992). In fact, the BST is one of the major targets
of noradrenergic innervation in the brain (Swanson and
Hartman, 1975; Moore, 1978). Noradrenergic terminals in
the BST originate from noradrenergic neurons in the A1,
A2 and A5 cell groups, as well as in the locus coeruleus
(Moore, 1978; Byrum and Guyenet, 1987; Woulfe et al.,
1988). Previous studies have pointed out the presence of
adrenoceptors and noradrenaline transporters in that nu-
cleus (Matsui and Yamamoto, 1984; Egli et al., 2005;
Crestani et al., 2008b). BST-noradrenergic neurotransmis-
sion has been suggested to modulate the cardiovascular
and baroreflex activity in resting animals (Crestani et al.,
2007, 2008a). Noradrenaline microinjection into the BST
has been reported to cause arterial pressure and HR
changes (Crestani et al., 2007). It has also been reported
that activation of BST 1-adrenoceptors modulates baro-
reflex activity in a similar manner to that observed during
exercise (Crestani et al., 2008a).
Given the involvement of BST-noradrenergic neu-
rotransmission in cardiovascular control, we hypothesized
an involvement of BST adrenoceptors in the control of
exercise-related cardiovascular adjustments in rats. To
test this hypothesis, we investigated the effect of microin-
jection into the BST of selective adrenoceptor antagonists
in pressor and tachycardiac responses elicited by an acute
bout of exercise on a rodent treadmill. Moreover, in order
to address whether changes in exercise-evoked cardio-
vascular responses induced by pharmacological manipu-
lation of BST noradrenergic neurotransmission were not
due to an indirect effect caused by an alteration in motor
activity, we studied whether adrenoceptor blockade in the
BST affects the performance motor in the open-field test.
EXPERIMENTAL PROCEDURES
Ethical approval and animals
Experimental procedures were carried out following protocols ap-
proved by the Ethical Review Committee of the School of Medicine of
Ribeirão Preto, which complies with the Guiding Principles for Re-
search Involving Animals and Human Beings of the American Phys-
iological Society. Fifty-six maleWistar rats weighing 170–190 g were
used in the present experiments. Animals were housed in plastic
cages in a temperature-controlled room at 25 °C in the Animal CareUnit of the Department of Pharmacology, School of Medicine of
Ribeirão Preto, University of São Paulo. They were kept under a
12:12 h light-dark cycle (lights on between 6:00 AM and 6:00 PM) and
had free access to water and standard laboratory food.
Surgical preparation
When animal body weight reached 230–250 g, and 5 days before
the trial, rats were anesthetized with tribromoethanol (250 mg/kg,
i.p.). After scalp anesthesia with 2% lidocaine the skull was ex-
posed and stainless-steel guide cannulas (26 G) were bilaterally
implanted into the BST at a position 1 mm above the site of
injection, using a stereotaxic apparatus (Stoelting, Wood Dale, IL,
USA). Stereotaxic coordinates for cannula implantation into the
BST were: AP8.6 mm from interaural; L4.0 mm from the
medial suture, V5.8 mm from the skull with a lateral inclination
of 23° (Paxinos and Watson, 1997). Cannulas were fixed to the
skull with dental cement and one metal screw. After surgery, the
animals received a poly-antibiotic (Pentabiotico®, Fort Dodge,
Brazil), with streptomycins and penicillins, to prevent infection,
and a nonsteroidal anti-inflammatory, flunixine meglumine (Bana-
mine®, Schering Plough, Brazil), for post-operation analgesia.
One day before the trial (Braga et al., 2000; De Angelis et al.,
2006; Higa-Taniguchi et al., 2009; Crestani et al., 2010b), rats
were anesthetized with tribromoethanol (250 mg/kg, i.p.) and a
catheter was inserted into the abdominal aorta through the fem-
oral artery, for arterial pressure and HR recording. The catheter
was tunneled under the skin and exteriorized on the animal’s
dorsum. After surgery, the nonsteroidal anti-inflammatory flunixine
meglumine (Banamine®, Schering Plough, Brazil) was adminis-
tered for post-operation analgesia.
Measurement of cardiovascular responses
On the day of the experiment, the arterial cannulas were connected
to a pressure transducer. The pulsatile arterial pressure was re-
corded using an HP-7754A preamplifier (Hewlett–Packard, Palo
Alto, CA, USA) and an acquisition board (MP100A, Biopac Systems
Inc, Goleta, CA, USA) connected to a personal computer. Mean
arterial pressure (MAP) and HR values were derived from pulsatile
arterial pressure recordings and were processed online.
Drug microinjection into the BST
The needles (33 G, Small Parts, Miami Lakes, FL, USA) used for
microinjection into the BST were 1 mm longer than the guide
cannulas and were connected to a hand-driven 2 l syringe (7002-
H, Hamilton Co., Reno, NV, USA) through PE-10 tubing. Nee-
les were carefully inserted into the guide cannulas without re-
training the animals and drugs were injected in a final volume of
00 nl (Alves et al., 2010; Crestani et al., 2010b). After a 30 s
eriod, the needle was removed and inserted into the second
uide cannula for microinjection into the contralateral BST. Drugs
icroinjected into the BST were dissolved in artificial cerebrospi-
al fluid (ACSF) (ACSF composition: 100 mM NaCl; 2 mM
a3PO4; 2.5 mM KCl; 1 mM MgCl2; 27 mM NaHCO3; 2.5 mM
aCl2; pH7.4).
Experimental protocol
Effect of ACSF, WB4101, RX821002 or propranolol microin-
jection into the BST on dynamic exercise-induced cardiovascular
changes. Before surgical preparation, the animals ran daily on
the rodent treadmill for at least 1 week at a speed of 0.3–0.8 km/h
and 0% grade for 10 min. This procedure aimed to select the
animals for their ability to walk on the treadmill and to familiarize
them to exercise on the treadmill. No electrical stimulation was
used to induce the animals to run.
On the trial day, animals were brought to the experimental
room in their home cages. Animals were allowed 1 h to adapt to
s
i
b
R
2
n
i
R
s
c
a
l
m
v
b
W
r
a
p
r
d
a
A
a
(
1
m
s
P
a
n
P
b
s
r
c
t
i
a
e
F. H. F. Alves et al. / Neuroscience 177 (2011) 74–8376the conditions of the experimental room, such as sound and
illumination, before starting MAP and HR recordings. The exper-
imental room had controlled temperature (25 °C) and was acous-
tically isolated from the main laboratory. Constant background
noise was generated by an air exhauster to minimize sound
interference within the experimental room. At least one additional
30 min period was allowed for baseline MAP and HR recording. In
the sequence, the first group received bilateral microinjection of
vehicle (ACSF, 100 nl, n7) into the BST (Crestani et al., 2006,
2010b); the second group received bilateral microinjection of the
elective 1-adrenoceptor antagonistWB4101 (10 nmol/100 nl, n7)
nto the BST (Crestani et al., 2008a,b); the third group received
ilateral microinjection of the selective 2-adrenoceptor antagonist
X821002 (10 nmol/100 nl, n6) into the BST (Crestani et al.,
008a,b); and the fourth group received bilateral microinjection of the
onselective -adrenoceptor antagonist propranolol (10 nmol/100 nl,
n5) into the BST (Crestani et al., 2008a,b). Ten minutes later, the
animals were submitted to an acute exercise test on the rodent
treadmill. The test consisted of exercise at 0.8 km/h for 6 min (Dufloth
et al., 1997; Higa-Taniguchi et al., 2009; Crestani et al., 2010b),
which corresponds to about 70% of the rats’ maximum running
capacity on the treadmill. Each animal received only one microinjec-
tion per brain side. An untreated group (n5), with no guide cannula
n the brain, was also included.
Effect of microinjection into the BST of ACSF, WB4101 or
X821002 in the open-field test. A different group of animals was
ubmitted to the open-field test. This protocol aimed to study whether
hanges in cardiovascular responses to exercise induced by block-
de of BST adrenoceptors were not due to an unspecific change in
ocomotor activity. For this, animals were divided into three experi-
ental groups: the first group received bilateral microinjection of
ehicle (ACSF, 100 nl, n6) into the BST; the second group received
ilateral microinjection of the selective 1-adrenoceptor antagonist
B4101 (10 nmol/100 nl, n6) into the BST; and the third group
eceived bilateral microinjection of the selective 2-adrenoceptor an-
tagonist RX821002 (10 nmol/100 nl, n6) into the BST. Ten minutes
fter BST pharmacological treatment animals were individually
laced on the centre of a circular arena (76.5 cm diameter sur-
ounded by 49-cm-high walls) made of dark transparent plastic. The
istance coursed by the animals was measured for 10 min. Motor
ctivity in the open field was videotaped and later analyzed with
nyMaze software (Stoelting, Wood Dale, IL, USA), which detects
nd calculates the distance moved by the animals.
Histological determination of the microinjection sites
At the end of experiments, animals were anesthetized with ure-
thane (1.25 g/kg, i.p.) and 100 nl of 1% Evan’s Blue dye was
injected into the BST as a marker of injection sites. They were
then submitted to intracardiac perfusion with 0.9% NaCl followed
by 10% formalin. Brains were removed and postfixed for 48 h at
4 °C and serial 40 m-thick sections were cut with a cryostat
CM1900, Leica, Wetzlar, Germany). Sections were stained with
% Neutral Red for light microscopy analysis. The actual place-
ent of the microinjection needles was determined by analyzing
erial sections and identified according to the rat brain atlas of
axinos and Watson (1997).
Drugs
WB4101 (Tocris, Westwoods Business Park Ellisville, MO, USA),
RX821002 (Tocris) and propranolol (Sigma, St. Louis, MO, USA)
were dissolved in ACSF. Urethane (Sigma) and tribromoethanol
(Sigma) were dissolved in saline (0.9% NaCl). Flunixine meglu-
mine (Banamine®, Schering Plough, Brazil) and poly-antibiotic
preparation of streptomycins and penicillins (Pentabiotico®, Fort
Dodge, Brazil) were used as provided.Statistical analysis
Data are presented as meanSEM. Basal values of MAP and HR
before and after BST pharmacological treatment were compared
using paired Student’s t-test. Time-course curves of MAP and HR
changes and of distance traveled during the open-field test were
compared using two-way ANOVA for repeated measurements
(treatment vs. time), with repeated measures on the second fac-
tor, followed by Bonferroni’s post test. Total distance travelled
during the open-field test and MAP and HR baseline values of all
experimental groups were compared using one-way ANOVA. Sig-
nificance was set at P0.05.
RESULTS
Determination of microinjection sites into the bed
nucleus of the stria terminalis
A representative photomicrograph of a coronal brain sec-
tion depicting bilateral microinjection sites in the BST of
one representative animal is presented in Fig. 1. Diagram-
matic representation showing microinjection sites of
ACSF, WB4101, RX821002 and propranolol into the BST
and WB4101 and RX821002 into structures surrounding
the BST is also shown in Fig. 1.
Effect of microinjection into the BST of ACSF,
WB4101, RX821002 or propranolol on dynamic
exercise-induced cardiovascular changes
MAP (F0.4, P0.05) and HR (F0.9, P0.05) baseline
values were similar in all experimental groups.
ACSF. Bilateral microinjection of ACSF (n7) into
the BST did not affect either MAP (993 vs. 983 mmHg,
t1.1, P0.05) or HR (34910 vs. 3528 bpm, t0.6,
P0.05) baseline values. Exercise-evoked cardiovascular
responses in animals that received ACSF injected into the
BST were not significantly different from those of the un-
treated group (n5) (Table 1 and Fig. 2).
WB4101. Bilateral microinjection of the selective 1-
drenoceptor antagonist WB4101 (n7) into the BST did
ot affect either MAP (982 vs. 963 mmHg, t1,
0.05) or HR (3668 vs. 3606 bpm, t0.5, P0.05)
aseline values. However, BST pretreatment with W4101
ignificantly increased the exercise-evoked tachycardiac
esponse without affecting the pressor response, when
ompared with animals that received ACSF injected into
he BST (Table 1 and Fig. 3). Microinjection of WB4101
nto structures surrounding the BST (n4), such as the
nterior comissure, internal capsule or fornix did not affect
ither MAP (F(1,171)0.3; P0.05) or HR (F(1,171)0.1;
P0.05) responses to exercise. Representative record-
ings showing the cardiovascular responses to exercise on
the treadmill in animals treated with ACSF or WB4101
injected into the BST are presented in Fig. 4.
RX821002. Bilateral microinjection of the selective
2-adrenoceptor antagonist RX821002 (n6) into the BST
did not affect either MAP (1003 vs. 994 mmHg, t0.4,
P0.05) or HR (3587 vs. 3638 bpm, t1.5, P0.05)
baseline values. However, pretreatment of the BST with
RX821002 significantly reduced exercise-evoked pressor
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when compared with animals that received ACSF injected
into the BST (Table 1 and Fig. 5). Microinjection of
RX821002 into structures surrounding the BST (n4),
such as the anterior comissure, internal capsule or fornix
did not affect either MAP (F(1,171)0.5; P0.05) or HR
(F(1,171)0.3; P0.05) response to exercise. Represen-
ative recordings showing the cardiovascular responses
o exercise on the treadmill in animals treated with ACSF
r RX821002 injected into the BST are presented in
ig. 6.
Propranolol. Bilateral microinjection of the nonselec-
ive -adrenoceptor antagonist propranolol (n5) into the
BST did not affect either MAP (962 vs. 972 mmHg,
t1.6, P0.05) or HR (34813 vs. 3559 bpm, t1.6,
P0.05) baseline values. Propranolol microinjection into
the BST also did not affect cardiovascular responses to
exercise on the treadmill (Fig. 7).
Fig. 1. Photomicrograph of a coronal brain section from one repres
epresentation based on the rat brain atlas of Paxinos and Watson (1
propranolol () into the BST, as well as WB4101 () and RX821002 (
oordinate; ic, internal capsule; LSV, lateral septal ventral; st, stria te
able 1. Statistical summary of time-course analysis of mean arterial pre
min). It was compared responses of groups vehicle (ACSF) (n7) vs
CSF, the selective 2-adrenoceptor antagonist RX821002 (n6) vs. AC
Treatment
CSF vs. untreated
MAP F(1,190)1
HR F(1,190)0.2
B4101 vs. ACSF
MAP F(1,228)3
HR F(1,228)343*
X821002 vs. ACSF
MAP F(1,209)177*
HR F(1,209)0.1
ropranolol vs. ACSF
MAP F(1,190)0.6
HR F(1,190)1P0.05, two-way ANOVA followed by Bonferroni’s post hoc test.Effect of microinjection into the BST of ACSF,
WB4101 or RX821002 in the open-field test
Bilateral microinjection of either WB4101 (n6) (123 vs.
143 m, P0.05) or RX821002 (n6) (123 vs. 132 m,
P0.05) into the BST did not affect total distance travelled
during the open-field test (F(2,17)0.1, P0.05), when
compared with animals treated with ACSF (n6) (Fig. 8B).
Time-course analysis of distance traveled during the open-
field test also did not show a significant effect of BST
adrenoceptor antagonism (F(2,150)1.1, P0.05), but
indicated a significant effect over time (F(9,150)50,
P0.0001) (Fig. 8A).
DISCUSSION
The present work brings the first direct evidence for the
involvement of CNS adrenoceptors in cardiovascular re-
sponses observed during dynamic exercise. We have
rat showing bilateral injection sites in the BST and a diagrammatic
icating injection sites of ACSF (Œ), WB4101 (), RX821002 () and
tructures surrounding the BST. ac, anterior commissure; IA, interaural
f, fornix.
AP) and heart rate (HR) responses to dynamic exercise (0.8 km/h for
ed (n5), the selective 1-adrenoceptor antagonist WB4101 (n7) vs.
the nonselective -adrenoceptor antagonist propranolol (n5) vs. ACSF
Time Interaction (treatment vs. time)
F(18,190)25* F(18,190)0.2
F(18,190)110* F(18,190)0.7
F(18,228)36* F(18,228)0.5
F(18,228)315* F(18,228)12*
F(18,209)12* F(18,209)6*
F(18,209)182* F(18,209)1
F(18,190)24* F(18,190)0.3
F(18,190)130* F(18,190)1.6entative
997), ind
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F. H. F. Alves et al. / Neuroscience 177 (2011) 74–8378shown that bilateral microinjection of WB4101, a selective
1-adrenoceptor antagonist, into the BST enhanced exer-
cise-evoked HR increase without affecting MAP response.
Moreover, BST treatment with RX821002, a selective 2-
adrenoceptor antagonist, reduced MAP increase observed
during dynamic exercise on the treadmill without changing
tachycardiac response. However, bilateral microinjection
into the BST of propranolol, a nonselective -adrenoceptor
ntagonist, did not affect cardiovascular responses to ex-
rcise on the treadmill.
Dynamic exercise causes cardiovascular responses,
hich include increases in arterial pressure, HR and car-
iac output, associated with decreased venous capaci-
ance and redistribution of blood to different territories
regional vasoconstriction or vasodilatation), via neural,
ormonal and local mechanisms (Winder et al., 1978;
ade, 1984; Waldrop et al., 1996; Michelini and Stern,
009). We have observed pressor and tachycardiac re-
ponse during dynamic exercise on the rodent treadmill.
ardiovascular responses reported in the present study
ere strictly related to exercise, and not due to exposure to
novel environment, since we have previously reported no
earful associations, including cardiovascular changes,
hen the animals were kept at rest on the treadmill (Cres-
ani et al., 2010b).
Fig. 2. Time-course of changes in mean arterial pressure (MAP) and
of the untreated group (Œ, n5), with no cannulas in the brain, and in
the BST. The onset of exercise was at t0. Circles represent the mea
MAP (P0.05) or HR responses (P0.05) to exercise on the treadm
Fig. 3. Time-course of changes in mean arterial pressure (MAP) and
in rats that had received bilateral microinjection of vehicle (ACSF, Œ, n
he onset of exercise was at t0. Circles represent the mean and bars
ollowed by Bonferroni’s post test. Microinjection of WB4101 into the BS
ffecting the pressor response (P0.05).Recently, we have demonstrated that CoCl2-induced
acute bilateral inhibition of BST neurotransmission greatly
attenuated both pressor and tachycardiac responses
evoked by exercise on the treadmill (Crestani et al.,
2010b). However, due to the nonselective blockade of
local neurotransmission caused by CoCl2 (Kretz, 1984;
Lomber, 1999), the possible neurotransmitter involved was
not identified. The present work has demonstrated that
blockade of 2-adrenoceptors by bilateral microinjection of
RX821002 into the BST is able to reduce exercise-evoked
pressor response without changing HR response. This
result suggests that local 2-adrenoceptor mediates, at
east in part, BST influence on MAP response during ex-
rcise. Although our results indicate a role of 1-adreno-
ceptor in modulation of the tachycardiac response evoked
by exercise, the blockade of 1-adrenoceptor in the BST
ffected HR response in an opposite manner to that ob-
erved after BST treatment with CoCl2. Therefore, further
xperiments are necessary to clarify the neurotransmitter
nd the receptors in the BST which are involved in its
nfluence on tachycardiac response to exercise. However,
he enhancement in exercise-evoked HR increase after the
lockade of BST 1-adrenoceptors led to the interesting
observation of a reserve in the cardiac response to our
exercise protocol. Moreover, this result indicates an impor-
te ( HR) during dynamic exercise on the treadmill (0.8 km/h for 6 min)
t had received bilateral microinjection of vehicle (ACSF, , n7) into
rs the SEM. Microinjection of ACSF into the BST did not affect either
te ( HR) during dynamic exercise on the treadmill (0.8 km/h for 6 min)
selective 1-adrenoceptor antagonist WB4101 (, n7) into the BST.
, * P0.05 compared with ACSF, two-way ANOVA (treatment vs. time)
ced the HR increase evoked by dynamic exercise (P0.0001) withoutheart ra
rats tha
n and baheart ra
7) or the
the SEM
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F. H. F. Alves et al. / Neuroscience 177 (2011) 74–83 79tant physiological meaning of BST 1-adrenoceptor in the
control of cardiovascular activity during exercise, since
activation of this receptor counteracts excessive cardiac
activation. Thus, BST 1-adrenoceptor plays an important
ole in achieving fine tuning of the cardiac response during
xercise, thus ensuring the functional state stabilization of
he cardiac activity during exercise since the amplitude of
he response is reduced.
We have observed that animals treated with either
B4101 or RX821002 injected into the BST behaved in a
imilar manner in the open-field test as compared to rats
reated with vehicle, indicating that blockade of adrenocep-
ors in the BST did not influence motor performance. Al-
hough connections between the BST and CNS locomotor
egions have been reported (Dong et al., 2001; Dong and
wanson, 2004), previous studies from our group and
ther laboratories also reported absence of effects in the
pen-field test after BST electrolytic lesion or chemical
blation in both male and female rats (Schulz and Can-
eyli, 2000; Pezuk et al., 2006, 2008; Resstel et al., 2008;
restani et al., 2010a,b). These results suggest that
hanges in cardiovascular responses to dynamic exercise
bserved in the present study after BST pharmacological
reatment is due to a direct interference in autonomic con-
Fig. 4. Recording from representative animals illustrating changes in
(HR) observed during dynamic exercise on the treadmill after BST treat
ote the increase in the HR response to exercise in the animal that r
Fig. 5. Time-course of changes in mean arterial pressure (MAP) and
in rats that had received bilateral microinjection of vehicle (ACSF, Œ,
BST. The onset of exercise was at t0. Circles represent the mean an
vs. time) followed by Bonferroni’s post test. Microinjection of RX821002 into
(P0.0001) without affecting the tachycardiac response (P0.05).rol, and not to an indirect effect caused by an alteration in
otor activity.
According to current theory, circulatory control during
xercise is governed by the CNS through several neural
echanisms (Raven et al., 2002; Fisher and White, 2004).
entral command is a feed-forward mechanism originating
n higher brain centers that involves the parallel activation
f brainstem and spinal circuits responsible for the control
f locomotion as well as cardiovascular activity during
xercise (Raven et al., 2002; Fisher and White, 2004;
illiamson et al., 2006). Neuroimaging and immunohisto-
hemical studies have indicated that the neural pathway of
entral command appears to encompass regions of the
erebral cortex and hypothalamus involved in control of
utonomic functions, such as the insular cortex, medial
refrontal cortex, paraventricular nucleus of the hypothal-
mus and lateral hypothalamus (Timofeeva et al., 2003;
illiamson et al., 2006; Williamson, 2010), which interact
ith other structures involved in locomotor and cardiovas-
ular integration during exercise (Raven et al., 2002; Wil-
iamson et al., 2006). Connections between the BST and
hese cortical and hypothalamic structures were previously
escribed (Yasui et al., 1991; Dong et al., 2001; Vertes,
004). In this way, it has been proposed that the BST could
arterial pressure (PAP), mean arterial pressure (MAP) and heart rate
vehicle (ACSF) or the selective 1-adrenoceptor antagonist WB4101.
B4101 injected into the BST.
te ( HR) during dynamic exercise on the treadmill (0.8 km/h for 6 min)
he selective 2-adrenoceptor antagonist RX821002 (, n6) into the
e SEM, * P0.05 compared with ACSF, two-way ANOVA (treatmentpulsatile
ment withheart ra
n7) or t
d bars ththe BST reduced the MAP increase evoked by dynamic exercise
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F. H. F. Alves et al. / Neuroscience 177 (2011) 74–8380be a relay in the neural circuitry of cardiovascular control,
connecting telencephalic structures to autonomic regions
in the hypothalamus and brainstem (Ulrich-Lai and Her-
man, 2009). Therefore, control of exercise-evoked cardio-
vascular responses by BST adrenoceptors proposed in the
present study can occur through a modulation of signals
arising from cortical structures to the BST.
Cardiovascular adjustment during exercise is also
driven by type III and IV muscle afferent activity from
exercising muscles, which provide feedback regarding the
mechanical and metabolic conditions within those muscles
(Kaufman and Forster, 1996; Fisher and White, 2004;
Potts, 2006). Although medullary structures appear to be
the primary pathway involved in the feedback control from
active muscles, supramedullary nuclei may play a modu-
lating role that can affect the reflex control of autonomic
activity during exercise (Waldrop and Stremel, 1989; Kauf-
man and Forster, 1996; Li, 2004). Studies in the literature
have shown that static muscle contraction activates brain
stem regions consisting of noradrenergic cells (Li et al.,
1998), thus indicating that the reflex from active muscles
involves central noradrenergic pathways. Therefore, BST
noradrenergic neurotransmission could also be part of the
pathway of feedback control from active muscle receptors.
However, although the activation of 2-adrenoceptor in the
Fig. 6. Recording from representative animals illustrating changes in
(HR) observed during dynamic exercise on the treadmill after BST
X821002. Note the decrease in the arterial pressure response to ex
Fig. 7. Time-course of changes in mean arterial pressure (MAP) and
in rats that had received bilateral microinjection of vehicle (ACSF, Œ,
the BST. The onset of exercise was at t0. Circles represent the me
either MAP (P0.05) or HR responses (P0.05) to exercise on the treadmill.NS elicited by administration of clonidine, a selective
2-adrenoceptor agonist, decreases the pressor and
tachycardiac response evoked by static muscle contrac-
tion (Williams, 1985; Ally et al., 1996), it has been docu-
mented that the selective 2-adrenoceptor antagonist yo-
mbine does not affect the cardiovascular responses
voked by static exercise when injected either into the
ateral ventricle or cerebral aqueduct (Williams et al., 1987;
lly et al., 1996). These results indicate absence of a tonic
nfluence of 2-adrenoceptor on the neurons regulating the
cardiovascular responses to static exercise. In this way, a
possible involvement of BST noradrenergic neurotrans-
mission in the pathway of feedback control from active
muscle receptors is not mediated by activation of local
2-adrenoceptors.
It has been reported that the baroreflex stimulus–re-
ponse curve resets during exercise, with a vertical up-
ard shift on the response arm and a lateral rightward shift
o higher operating pressures (Rowell and O’Leary, 1990;
iCarlo and Bishop, 2001; Raven et al., 2006; Dampney et
l., 2008). It has been proposed that the central command
nd reflex mechanism from active muscles may exert its
ffects on cardiovascular parameters by changing baroreflex
ctivity (Raven et al., 2002; Potts, 2006). Previous results
rom our laboratory indicated that BST noradrenergic neu-
arterial pressure (PAP), mean arterial pressure (MAP) and heart rate
t with vehicle (ACSF) or the selective 2-adrenoceptor antagonist
the animal that received RX821002 injected into the BST.
te ( HR) during dynamic exercise on the treadmill (0.8 km/h for 6 min)
he nonselective -adrenoceptor antagonist propranolol (, n5) into
rs the SEM. Microinjection of propranolol into the BST did not affectpulsatile
treatmenheart ra
n7) or t
an and baTwo-way ANOVA (treatment vs. time).
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F. H. F. Alves et al. / Neuroscience 177 (2011) 74–83 81rotransmission, through activation of 1-adrenoceptor, mod-
ulates the baroreflex activity in a similar manner to that ob-
served during exercise (Crestani et al., 2008a). This result
suggests that activation of BST 1-adrenoceptors could facil-
itate cardiovascular responses to dynamic exercise through
its modulation of baroreflex activity. However, results re-
ported in the present study indicate an inhibitory influence of
BST 1-adrenoceptors on the exercise-induced HR increase.
his evidence suggests that BST noradrenergic neurotrans-
ission affects exercise-induced cardiovascular responses
y a mechanism independent of baroreflex modulation.
hese results corroborate with previous data indicating that
ST stimulation evokes similar cardiovascular responses in
ham animals or those submitted to sinoaortic denervation
i.e. baroreflex denervation) (Dunn and Williams, 1998).
Both the sympathetic and the parasympathetic branches
f the autonomic nervous system participate in the control
f cardiovascular activity during dynamic exercise. Block-
de of parasympathetic control of HR reveals that most of
he initial response to exercise is attributable to the with-
Fig. 8. (A) Time-course of the distance travelled when exposed to the
open-field test by animals that received vehicle (ACSF, Œ, n6), the
elective 1-adrenoceptor antagonist WB4101 (, n6), or the selec-
tive 2-adrenoceptor antagonist RX821002 (, n6) injected into the
ST. Circles represent the means and bars the SEM. BST pharma-
ological treatment did not affect the motor performance in the open-
eld test (P0.05). Two-way ANOVA (treatment vs. time). (B) Total
istance travelled by rats exposed to the open-field test shown by
nimals treated with ACSF (white bar), WB4101 (black bar) or
X821002 (gray bar) injected into the BST. BST pretreatment with
ither WB4101 (P0.05) or RX821002 (P0.05) did not modify the rat
ocomotor activity in the open-field test, when compared with animals
reated with ACSF. One-way ANOVA.rawal of tonic vagal activity, whereas -adrenergic block-ade reveals the importance of augmented cardiac sympa-
thetic activity during moderate and heavy exercise (Over-
ton, 1993; Goldsmith et al., 2000). The BST sends direct
projections to medullary structures involved with auto-
nomic activity, such as the nucleus of the tractus solitarius
(NTS), dorsal motor nucleus of the vagus, nucleus am-
biguus and ventrolateral medulla (Gray and Magnuson,
1987; Dong and Swanson, 2004). In this way, it was dem-
onstrated that ablation of the caudal ventrolateral medulla
(CVLM) attenuated MAP and HR decreases elicited by
BST stimulation (Giancola et al., 1993). The CVLM proj-
ects to and inhibits sympathetic premotor neurons in the
rostral ventrolateral medulla, thus decreasing sympa-
thetic preganglionic neuronal outflow (Sved et al., 2000).
Previous evidence has also indicated an involvement of
the NTS in cardiovascular control during exercise (Du-
floth et al., 1997; Raven et al., 2006; Higa-Taniguchi et
al., 2009). These results provide evidence of the neural
substrate for the influence of BST 1-adrenoceptor on
exercise-related HR response. Thus, BST 1-adreno-
ceptors could modulate the cardiac response during
exercise by stimulating facilitatory inputs to vagal neu-
rons and/or by stimulating inhibitory inputs to sympa-
thetic medullary neurons. Connections from the BST to
the medulla could also be the neural substrate for the
facilitatory influence of BST 2-adrenoceptors on the
pressor response to exercise.
The existence of specific neuronal pathways control-
ling autonomic activity to different organs provides the
structural substrate for differences between BST 1- and
2-adrenoceptors in modulating cardiovascular adjust-
ents during dynamic exercise (Morrison, 2001). There-
ore, subtypes of -adrenoceptors in the BST may modu-
ate the activity of specific neural pathways in the CNS,
hus differentially affecting exercise-evoked pressor and
achycardiac responses. Present results corroborate
ith previous results that indicated specific actions of
ST 1- or 2-adrenoceptors on cardiovascular control
(Crestani et al., 2008a, 2009a). On the other hand, it
was reported that cardiovascular responses evoked by
microinjection of noradrenaline into the BST are medi-
ated by activation of both 1- and 2-adrenoceptors in
he BST (Crestani et al., 2008b). Because different ex-
erimental procedures were used in these studies with
ifferent response parameters being analyzed, it is pos-
ible that BST 1- and 2-adrenoceptors have similar or
different roles depending on the stimulus.
BST treatment with adrenoceptor antagonists did not
affect either MAP or HR baseline values. Therefore,
although the present study supports the hypothesis that
BST noradrenergic neurotransmission plays an impor-
tant role in modulating the cardiovascular responses to
dynamic exercise, this neurotransmission is not involved
in the tonic maintenance of either arterial pressure or
HR. These results corroborate previous data in the lit-
erature indicating no changes in cardiovascular param-
eters after blockade of either glutamatergic, cholinergic
or adrenergic receptors in the BST (Alves et al., 2007;
Hatam and Nasimi, 2007; Crestani et al., 2008a, 2009a).
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F. H. F. Alves et al. / Neuroscience 177 (2011) 74–8382CONCLUSION
In conclusion, the present results show that noradrenergic
neurotransmission in the BST modulates cardiovascular ad-
justments during dynamic exercise in a complex way. Our
data provide evidence of an inhibitory influence of BST 1-
adrenoceptors on exercise-evoked HR response. Moreover,
the results point to a facilitatory role played by the activation
of BST 2-adrenoceptors on pressor response to dynamic
xercise. These results provide the first direct evidence for
he involvement of CNS adrenoceptors in cardiovascular re-
ponses observed during dynamic exercise.
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